Androgen receptor stops tumor growth in the most common form of breast cancer

(The Endocrine Society) Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments. They will present the results of their new preclinical study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

Condition:   Breast Cancer Invasive Interventions:   Drug: Pyrotinib;   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Nab-paclitaxel;   Drug: EC chemotherapy;   Drug: Physician's choice;   Drug: T-DM1;   Procedure: Surgery Sponsors:   Shanghai Jiao Tong University School of Medicine;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Drug: RC48-ADC;   Drug: Paclitaxel Injection;   Drug: Docetaxel Injection;   Drug: Vinorelbine Tartrate Injection;   Drug: Capecitabine Tablets Sponsor:   RemeGen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 24 May 2020Source: Seminars in Cancer BiologyAuthor(s): Keng Wong Kah
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Discussion Galactorrhea is a milky discharge from the breast in a non-lactating female. Neonatal galactorrhea is sometimes called “Witch’s Milk” based on ideas from the 17th century or earlier that witches would steal the milk for use in their magic. Infant breasts were often compressed to express the fluid and prevent its collection. During the 19th century, reports of breast inflammation and even abscess were reported because of this practice and it was strongly discouraged, and continues to not be recommended today. Enlargement of neonatal breasts and galactorrhea, both for males and females, is fel...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Publication date: Available online 24 May 2020Source: Artificial Intelligence in MedicineAuthor(s): Mireia Vilardell, Maria Buxó, Ramon Clèries, José Miguel Martínez, Gemma Garcia, Alberto Ameijide, Rebeca Font, Sergi Civit, BreCanSurvCat working group
Source: Artificial Intelligence in Medicine - Category: Bioinformatics Source Type: research
Condition:   Breast Cancer Invasive Interventions:   Drug: Pyrotinib;   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Nab-paclitaxel;   Drug: EC chemotherapy;   Drug: Physician's choice;   Drug: T-DM1;   Procedure: Surgery Sponsors:   Shanghai Jiao Tong University School of Medicine;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Drug: RC48-ADC;   Drug: Paclitaxel Injection;   Drug: Docetaxel Injection;   Drug: Vinorelbine Tartrate Injection;   Drug: Capecitabine Tablets Sponsor:   RemeGen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study assessed the feasibility and effectiveness of WCIs for increasing physical activity in breast cancer survivors; secondary measures included changes in dietary habits, weight, and QOL. METHODS: 20 obese or overweight breast cancer survivors who recently completed active breast cancer treatment were recruited into a single-arm, 12-week WCI pilot feasibility study. The intervention was comprised of one in-person wellness coaching visit followed by four telephone calls over 12 weeks and 12 weekly emails containing wellness recommendations. FINDINGS: Significant improvements from pre- to postintervention we...
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Clin J Oncol Nurs Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Study